Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets

FRONTIERS IN ONCOLOGY

FRONTIERS MEDIA SA

1. European Regional Development Fund (ERDF), through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalization [POCI-01-0145-FEDER-028147, UIDB/04539/2020, UIDP/04539/2020, LA/P/0058/2020, PTDC/MED-ONC/28636/2017]
2. Portuguese national funds via FCT - Fundacao para a Ciencia e a Tecnologia [POCI-01-0145-FEDER-028147, UIDB/04539/2020, UIDP/04539/2020, LA/P/0058/2020, PTDC/MED-ONC/28636/2017]
3. Programa de Financiamiento para la Investigacion, UNAM, Mexico [PAPIIT-IN231420]
4. National Institute for Biotechnology in the Negev (NIBN), Ben-Gurion University, Beer Sheva, Israel
5. Fundação para a Ciência e a Tecnologia [PTDC/MED-ONC/28636/2017] Funding Source: FCT